Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia over 45 years of age and over
- Santoro N.
- Labopin M.
- Ciceri F.
- Van Lint M. T.
- Nasso D.
- Blaise D.
- Arcese W.
- Tischer J.
- Bruno B.
- Ehninger G.
- Koc Y.
- Santarone S.
- Huang X. -J.
- Savani B. N.
- Mohty M.
- Ruggeri A.
- Nagler A.
Publication date
January 2019
DOIAbstract
T cell-replete haploidentical stem cell transplantation (haplo-SCT) is a valid therapeutic option for adult patients with high-risk acute myeloid leukemia (AML) lacking an HLA-matched sibling or unrelated donor
Add to ORKG